Literature DB >> 30002103

A systematic review of how patients value COPD outcomes.

Yuan Zhang1, Rebecca L Morgan1, Pablo Alonso-Coello1,2, Wojtek Wiercioch1, Małgorzata M Bała3, Rafał R Jaeschke4, Krzysztof Styczeń4, Hector Pardo-Hernandez2, Anna Selva5,6, Housne Ara Begum1, Gian Paolo Morgano1, Marcin Waligóra7, Arnav Agarwal1,8, Matthew Ventresca1, Karolina Strzebońska7, Mateusz T Wasylewski7, Lídia Blanco-Silvente9, Janna-Lina Kerth10, Mengxiao Wang1, Yuqing Zhang1, Saiprasad Narsingam11, Yutong Fei12, Gordon Guyatt1,13, Holger J Schünemann1,13.   

Abstract

Our objective was to summarise systematically all research evidence related to how patients value outcomes in chronic obstructive pulmonary disease (COPD).We conducted a systematic review (systematic review registration number CRD42015015206) by searching PubMed, Embase, PsycInfo and CINAHL, and included reports that assessed the relative importance of outcomes from COPD patients' perspective. Two authors independently determined the eligibility of studies, abstracted the eligible studies and assessed risk of bias. We narratively summarised eligible studies, meta-analysed utilities for individual outcomes and assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluations approach.We included 217 quantitative studies. Investigators most commonly used utility measurements of outcomes (n=136), discrete choice exercises (n=13), probability trade-off (n=4) and forced choice techniques (n=46). Patients rated adverse events as important but on average, less so than symptom relief. Exacerbation and hospitalisation due to exacerbation are the outcomes that COPD patients rate as most important. This systematic review provides a comprehensive registry of related studies. The content of this work is copyright of the authors or their employers. Design and branding are copyright ©ERS 2018.

Entities:  

Mesh:

Year:  2018        PMID: 30002103     DOI: 10.1183/13993003.00222-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  24 in total

1.  Update in Chronic Obstructive Pulmonary Disease 2018.

Authors:  Wassim W Labaki; Lucas M Kimmig; Gökhan M Mutlu; MeiLan K Han; Surya P Bhatt
Journal:  Am J Respir Crit Care Med       Date:  2019-06-15       Impact factor: 21.405

2.  Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.

Authors:  Hana Müllerová; Mark T Dransfield; Byron Thomashow; Paul W Jones; Stephen Rennard; Niklas Karlsson; Malin Fageras; Norbert Metzdorf; Stefano Petruzzelli; Jean Rommes; Frank C Sciurba; Maggie Tabberer; Debora Merrill; Ruth Tal-Singer
Journal:  Am J Respir Crit Care Med       Date:  2020-05-01       Impact factor: 21.405

Review 3.  Methods to Summarize Discrete-Choice Experiments in a Systematic Review: A Scoping Review.

Authors:  Daksh Choudhary; Megan Thomas; Kevin Pacheco-Barrios; Yuan Zhang; Pablo Alonso-Coello; Holger Schünemann; Glen Hazlewood
Journal:  Patient       Date:  2022-07-13       Impact factor: 3.481

4.  National clinical audit for hospitalised exacerbations of COPD.

Authors:  John R Hurst; Jennifer K Quint; Robert A Stone; Yvonne Silove; Jane Youde; C Michael Roberts
Journal:  ERJ Open Res       Date:  2020-09-21

5.  Prioritization and Refinement of Patient-Informed Value Elements as Attributes for Chronic Obstructive Pulmonary Disease Treatment Preferences.

Authors:  Julia F Slejko; Yoon Duk Hong; Jamie L Sullivan; Robert M Reed; Susan dosReis
Journal:  Patient       Date:  2021-02-08       Impact factor: 3.883

6.  Validation of COPDPredict™: Unique Combination of Remote Monitoring and Exacerbation Prediction to Support Preventative Management of COPD Exacerbations.

Authors:  Neil Patel; Kathryn Kinmond; Pauline Jones; Pamela Birks; Monica A Spiteri
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-06-21

7.  Self-management interventions for adults living with Chronic Obstructive Pulmonary Disease (COPD): The development of a Core Outcome Set for COMPAR-EU project.

Authors:  Estela Camus-García; Ana Isabel González-González; Monique Heijmans; Ena Niño de Guzmán; Claudia Valli; Jessica Beltran; Hector Pardo-Hernández; Lyudmil Ninov; Valentina Strammiello; Kaisa Immonen; Dimitris Mavridis; Marta Ballester; Rosa Suñol; Carola Orrego
Journal:  PLoS One       Date:  2021-03-01       Impact factor: 3.240

8.  Blood Eosinophils and Clinical Outcomes in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Propensity Score Matching Analysis of Real-World Data in China.

Authors:  Yanan Cui; Zijie Zhan; Zihang Zeng; Ke Huang; Chen Liang; Xihua Mao; Yaowen Zhang; Xiaoxia Ren; Ting Yang; Yan Chen
Journal:  Front Med (Lausanne)       Date:  2021-06-09

9.  Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study.

Authors:  Gary T Ferguson; Alberto Papi; Antonio Anzueto; Edward M Kerwin; Christy Cappelletti; Elizabeth A Duncan; Jack Nyberg; Paul Dorinsky
Journal:  Eur Respir J       Date:  2018-09-16       Impact factor: 16.671

10.  Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain.

Authors:  Bernardino Alcázar-Navarrete; Francisco García-Rio; Guadalupe Sánchez; Esther Mariscal; Andrea García; Maribel Cuesta; Estefany Uría; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.